Yohimbine in neurally mediated syncope. Pathophysiological implications - Wikidata - wikimedia - TriplyDB

Yohimbine in neurally mediated syncope. Pathophysiological implications

Yohimbine in neurally mediated syncope. Pathophysiological implications

http://www.wikidata.org/entity/Q33175869

about

Management of vasovagal syncope: 2004.Non-invasive management of vasovagal syncope.Neuronal source of plasma dopamine.Neurocardiology: therapeutic implications for cardiovascular disease Concepts of scientific integrative medicine applied to the physiology and pathophysiology of catecholamine systems.Sympathoneural and adrenomedullary responses to mental stress Relationship between blood pressure, sleep K-complexes, and muscle sympathetic nerve activity in humans.

P2860

Q33151984-2A3C41D2-7107-43D2-95BA-14D2AD2D89E2 Q33164487-D2D2BFC3-DE51-4F11-9969-BD3747924661 Q36958597-A574708F-C94D-40DA-942D-E4E81F0E10B1 Q36969356-3F7D2AA5-5E2A-473E-8EF4-D3C8385CEC2A Q36992085-80946ECB-6A4D-4269-AE3E-03786A3B9C6D Q37614066-066B95F5-D8BA-4F5D-AD1B-1EE2B6334237 Q48626277-A59CB0A1-6B47-4BEF-A482-1DA0B8DFF3E8

P2860

Yohimbine in neurally mediated syncope. Pathophysiological implications

http://www.wikidata.org/entity/Q33175869

description

1998 nî lūn-bûn

@nan

1998 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Yohimbine in neurally mediated syncope. Pathophysiological implications

@ast

Yohimbine in neurally mediated syncope. Pathophysiological implications

@en

type

label

Yohimbine in neurally mediated syncope. Pathophysiological implications

@ast

Yohimbine in neurally mediated syncope. Pathophysiological implications

@en

prefLabel

Yohimbine in neurally mediated syncope. Pathophysiological implications

@ast

Yohimbine in neurally mediated syncope. Pathophysiological implications

@en

P1433

Q33175869-7DB2C398-7108-4BD6-9397-41363BC9383F

P1476

Q33175869-67BD0165-D501-4F63-BC1D-7E9B4DE2DA51

P2093

Q33175869-00E340FD-8ED6-4E16-81AE-D97C11E5B721

Q33175869-18231721-6621-44A8-933C-78DB343F71AD

Q33175869-559E9206-98EB-40D2-A58C-A9C3595DC9D1

Q33175869-717B79F1-3ADC-4856-B62E-9B33F0A10F50

Q33175869-93DA50EE-B5BA-49A9-924D-43904C07F306

Q33175869-B9B0A6E2-E3EC-44C0-A6D6-4C73F3EF2540

P2860

Q33175869-00BDBA5C-C422-4315-9B6C-094B695054F9

Q33175869-0170F111-964A-4CF2-B58C-2F4FFFA0B949

Q33175869-028B8F72-2E7D-4AFA-9F90-CA63603A49FC

Q33175869-0376325A-4C13-48FF-84F8-DED9F5BB6B1D

Q33175869-0C0D491D-DEC4-4003-A6AC-A2F7CCBD5BCF

Q33175869-103D1563-3A73-418C-9A16-743432B6294D

Q33175869-10C3F162-D1F3-4510-96AC-BF121D8BE5B4

Q33175869-1314FEA5-A281-4CBA-87C9-FB282B214E34

Q33175869-159CF888-34F5-4481-AB0E-1BFD589F12B5

Q33175869-3F8D7F63-D625-4528-846D-4B6E9670B259

P304

Q33175869-5F7F75B9-F54E-4715-9A59-57405FA0523A

P31

Q33175869-06D21FE7-C52E-496D-93D9-11E912B1B06E

P356

Q33175869-AE920CC4-BE12-4EF3-AD35-8F94065BDC41

P407

Q33175869-3DD92C3E-7D38-4A36-B308-4326E8F68FF6

P433

Q33175869-DE2A6EF7-C957-4D75-BA51-9C0F4AACD670

P478

Q33175869-B7F8CC8A-3702-458E-83AE-DE775CD2945B

P577

Q33175869-532A5B24-572B-470A-8909-2B67B6D2C3E6

P698

Q33175869-AA219B10-C729-4470-9E6F-87736D83E7F1

P921

Q33175869-609A7EC0-E46C-42DB-BE45-F0BFF88D6DDA

Q33175869-79F613EF-EABA-4473-B507-B8785C052005

P932

Q33175869-794A27FA-DE52-4526-8FAC-5B43F80C066B

P356

P1433

Journal of Clinical Investigation

P1476

Yohimbine in neurally mediated syncope. Pathophysiological implications

@en

P2093

G Cunningham

http://www.w3.org/2001/XMLSchema#string

J Tank

http://www.w3.org/2001/XMLSchema#string

M Snell

http://www.w3.org/2001/XMLSchema#string

R Fernandez-Violante

http://www.w3.org/2001/XMLSchema#string

R Furlan

http://www.w3.org/2001/XMLSchema#string

R Mosqueda-Garcia

http://www.w3.org/2001/XMLSchema#string

P2860

Syncope. Physiological considerations and an analysis of the clinical characteristics in 510 patients.

The vasovagal response.

The incidence of malignant vasovagal syndrome in patients with recurrent syncope.

Cardiovascular and catecholamine responses to head-up tilt in the diagnosis of recurrent unexplained syncope in elderly patients.

Vasovagal syncope after infusion of a vasodilator in a heart-transplant recipient.

The usefulness of head-up tilt testing and hemodynamic investigations in the workup of syncope of unknown origin.

Isoproterenol induction of vasodepressor-type reaction in vasodepressor-prone persons.

Cardiac electrophysiologic and hemodynamic correlates of neurally mediated syncope.

Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope.

Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man.

P304

1824-1830

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI3050

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P577

1998-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9819368

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology

P932

509132

http://www.w3.org/2001/XMLSchema#string